Author

P. C. Evans

Primary ORCID profile (0000-0001-7975-681X · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

P. C. EvansiD1 paper · Queen Mary University of London

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Mammoto· 1 shared B. Tardajos Ayllon· 1 shared C. L. Miller· 1 shared D. Pirri· 1 shared E. Chambers· 1 shared E. Osto· 1 shared F. Botre· 1 shared F. Donati· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPhysiology

A. Mammoto

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

EPAS1 Attenuates Atherosclerosis Initiation at Disturbed Flow Sites through Endothelial Fatty Acid Uptake

D. Pirri, S. Tian, B. Tardajos Ayllon, S. Irving, F. Donati, S. Allen, T. Mammoto, G. Vilahur, C. L. Miller, T. Schenkel, E. Chambers, M. J. Dunning, J. Serbanovic-Canic, F. Botre, A. Mammoto, , P. C. Evans

This study shows EPAS1 reduces atherosclerosis at disturbed flow sites by promoting endothelial fatty acid uptake and metabolism, which is suppressed in obesity through triglyceride-PHD3 pathway.

bioRxiv · Dec 5, 2023Physiology